| Subjects |
No. of cases |
GSH (mg/dl) |
GST (IU/L) |
GPx (nmol/min/ml) |
| Healthy controls |
30 |
3.96±1.18 |
1.81±1.21 |
24.22±3.53 |
| Breast cancer patients |
| Stage II before chemotherapy |
30 |
2.84±0.42e |
12.58±3.90a |
51.79±8.55a |
| Stage II after first cycle of chemotherapy |
30 |
1.89±0.40ab |
5.33±1.54ab |
36.53±5.62ab |
| Stage III before chemotherapy |
30 |
2.33±0.82ab |
13.01±3.79ab |
69.11±16.50ab |
| Stage III after first cycle chemotherapy |
30 |
1.79±0.53ac |
5.96±1.38ac |
50.31±13.07ac |
The data was expressed as Mean ± SD.
a P<0.0001 Significant when compared to healthy controls.
e P=0.0004 Significant when compared to healthy controls.
b P<0.0001 Significant when compared to stage II breast cancer patients before chemotherapy.
c P<0.0001 Significant when compared to stage III breast cancer patients before chemotherapy. |